Taysha Gene Therapies, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Taysha Gene Therapies, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Taysha Gene Therapies, Inc. Depreciation for the quarter ending September 30, 2024 was $300K, unchanged year-over-year.
  • Taysha Gene Therapies, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.27M, a 5.81% decline year-over-year.
  • Taysha Gene Therapies, Inc. annual Depreciation for 2023 was $1.37M, a 17% increase from 2022.
  • Taysha Gene Therapies, Inc. annual Depreciation for 2022 was $1.17M, a 138% increase from 2021.
  • Taysha Gene Therapies, Inc. annual Depreciation for 2021 was $492K, a 5367% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.37M +$199K +17% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $1.17M +$680K +138% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $492K +$483K +5367% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $9K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.